These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 12705627)

  • 21. Rubella seroprevalence among first-grade primary school students in a district in Istanbul, Turkey.
    Ay P; Topuzoglu A; Korukluoglu G; Cali S
    Public Health; 2006 Mar; 120(3):267-73. PubMed ID: 16364385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rubella seroprevalence among young women taipei county after routine measles, mumps and rubella immunization program.
    Wang IJ; Hwang KC; Tsai YH; Wu YN; Chao SJ; Chen TE; Huang LM
    Acta Paediatr Taiwan; 2006; 47(1):14-7. PubMed ID: 17016964
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Seroepidemiology of Rubella in Mozambique, 2006-2014: Implications for Rubella Immunization in Settings With High Fertility Rates.
    Amade NA; Sultane T; Augusto O; Ali S; Jani IV; Gudo ES
    Pediatr Infect Dis J; 2016 Oct; 35(10):1062-8. PubMed ID: 27294311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rubella seroprevalence in pregnant women living with and without HIV in Soweto, South Africa.
    Gieles NC; Mutsaerts EAML; Kwatra G; Bont L; Cutland CL; Jones S; Moultrie A; Madhi SA; Nunes MC
    Int J Infect Dis; 2020 Feb; 91():255-260. PubMed ID: 31863878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IgM and IgG antibodies specific to rubella in child bearing women.
    Ahmed MU
    J Pak Med Assoc; 1992 May; 42(5):121-2. PubMed ID: 1507389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estimating the burden of rubella virus infection and congenital rubella syndrome through a rubella immunity assessment among pregnant women in the Democratic Republic of the Congo: Potential impact on vaccination policy.
    Alleman MM; Wannemuehler KA; Hao L; Perelygina L; Icenogle JP; Vynnycky E; Fwamba F; Edidi S; Mulumba A; Sidibe K; Reef SE
    Vaccine; 2016 Dec; 34(51):6502-6511. PubMed ID: 27866768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SEROPREVALENCE OF RUBELLA ANTIBODIES AMONG TURKISH AND FOREIGN WOMEN IN TURKEY.
    Gündem NS; Kalem F
    Southeast Asian J Trop Med Public Health; 2017 Jan; 48(1):65-72. PubMed ID: 29644821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Seroprevalence of rubella antibodies and determinants of susceptibility to rubella in a cohort of pregnant women in Canada, 2008-2011.
    Gilbert NL; Rotondo J; Shapiro J; Sherrard L; Fraser WD; Ward BJ
    Vaccine; 2017 May; 35(23):3050-3055. PubMed ID: 28461066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distinguishing between primary infection and reinfection with rubella vaccine virus by IgG avidity assay in pregnant women.
    Hamkar R; Jalilvand S; Abdolbaghi MH; Jelyani KN; Esteghamati A; Hagh-goo A; Mohktari-Azad T; Nategh R
    East Mediterr Health J; 2009; 15(1):94-103. PubMed ID: 19469431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of rubella-specific IgG antibody in non-immunized pregnant women in Maiduguri, north eastern Nigeria.
    Bukbuk DN; el Nafaty AU; Obed JY
    Cent Eur J Public Health; 2002 Jun; 10(1-2):21-3. PubMed ID: 12096678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Age specific rubella seroprevalence of an unvaccinated population of adolescents in Ankara, Turkey.
    Kanbur NO; Derman O; Kutluk T; Kinik E
    Jpn J Infect Dis; 2003 Feb; 56(1):23-5. PubMed ID: 12711822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of anti-rubella, anti-measles and anti-mumps IgG antibodies in neonates and pregnant women in Catalonia (Spain) in 2013: susceptibility to measles increased from 2003 to 2013.
    Plans P; de Ory F; Campins M; Álvarez E; Payà T; Guisasola E; Compte C; Vellbé K; Sánchez C; Lozano MJ; Aran I; Bonmatí A; Carreras R; Jané M; Cabero L
    Eur J Clin Microbiol Infect Dis; 2015 Jun; 34(6):1161-71. PubMed ID: 25666082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Seroprevalence of rubella antibodies in The Netherlands after 32 years of high vaccination coverage.
    Smits G; Mollema L; Hahné S; de Melker H; Tcherniaeva I; van der Klis F; Berbers G
    Vaccine; 2014 Apr; 32(16):1890-5. PubMed ID: 24513012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rubella virus infection and associated factors among pregnant women attending the antenatal care clinics of public hospitals in Hawassa City, Southern Ethiopia: a cross-sectional study.
    Tamirat B; Hussen S; Shimelis T
    BMJ Open; 2017 Oct; 7(10):e016824. PubMed ID: 28982820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
    Zäch K; Nicoara C; Germann D; Matter L
    Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rubella seroprevalence in the first birth cohort reaching fertility age after 20 years of two dose universal vaccination policy in Israel.
    Levine H; Ankol OE; Rozhavski V; Davidovitch N; Aboudy Y; Zarka S; Balicer RD
    Vaccine; 2012 Nov; 30(50):7260-4. PubMed ID: 23063839
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccination in secondary school students expedites rubella control and prevents congenital rubella syndrome.
    He H; Yan R; Tang X; Zhou Y; Deng X; Xie S
    BMC Infect Dis; 2016 Nov; 16(1):723. PubMed ID: 27899091
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The risk factors of exposure to rubella among pregnant women in Zaria 2013.
    Gubio AB; Mamman AI; Abdul M; Olayinka AT
    Pan Afr Med J; 2019; 32(Suppl 1):4. PubMed ID: 30949283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Seroprevalence of rubella antibodies in the State of São Paulo, Brazil, 8 years after the introduction of vaccine.
    Zanetta DM; Cabrera EM; Azevedo RS; Burattini MN; Massad E
    Vaccine; 2003 Sep; 21(25-26):3795-800. PubMed ID: 12922113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Age-stratified seroprevalence of measles, mumps and rubella (MMR) virus infections in Switzerland after the introduction of MMR mass vaccination.
    Matter L; Germann D; Bally F; Schopfer K
    Eur J Epidemiol; 1997 Jan; 13(1):61-6. PubMed ID: 9062781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.